Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HEPARIN-POLYPEPTIDE DUAL GRAFTED CYCLODEXTRIN SKELETON COMPOSITION WITH LUNG TARGETING, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/068927
Kind Code:
A1
Abstract:
A low molecular heparin-polypeptide-crosslinked cyclodextrin organic skeleton (LMW H-polypeptide-COF) composition with lung targeting and a preparation method therefor. Also disclosed are a drug-carrying LMWH-polypeptide-COF composition carrying a drug, which comprises an LMWH-polypeptide-COF composition, and an anti-tumor drug or a drug targeting the lungs. Further disclosed is a pharmaceutical composition, which comprises a drug-carrying LMWH-polypeptide-COF composition and a pharmaceutically acceptable carrier. The composition can be targeted at treating tumors, particularly lung cancer.

Inventors:
ZHANG JIWEN (CN)
HE YAPING (CN)
XIONG TING (CN)
WU LI (CN)
HE SIYU (CN)
ZHOU YONG (CN)
ZHOU PANPAN (CN)
CHEN JIACAI (CN)
Application Number:
PCT/CN2021/122163
Publication Date:
April 07, 2022
Filing Date:
September 30, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI INST MATERIA MEDICA CAS (CN)
International Classes:
A61K47/50; A61K9/00; A61K47/36; A61K47/40; A61K47/42; A61P35/00; C08B37/10; C08B37/16; C08G81/00
Foreign References:
CN111440253A2020-07-24
US20190314555A12019-10-17
Other References:
WANG, JIANGUO: "Study on the Multi-targeted Nanoparticles for Tumor Antiangiogenesis", CHINESE MASTER'S THESES FULL-TEXT DATABASE, 17 April 2019 (2019-04-17), pages 1 - 64, XP055917893
CHUNYU XIA ET AL.: "Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment", THERANOSTICS, vol. 9, no. 2, 1 January 2019 (2019-01-01), XP055917894, ISSN: 1838-7640
WANG FEN, LI YUANYUAN, SHEN YINGQIANG, WANG ANMING, WANG SHULING, XIE TIAN: "The Functions and Applications of RGD in Tumor Therapy and Tissue Engineering", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 14, no. 7, 1 January 2013 (2013-01-01), pages 13447 - 13462, XP055917895, DOI: 10.3390/ijms140713447
Attorney, Agent or Firm:
XU&PARTNERS, LLC. (CN)
Download PDF: